A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 • 5,383 citations
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
2000 • 1,359 citations
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
2001 • 1,126 citations
Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation
2002 • 713 citations
The IL-2 Receptor Complex: Its Structure, Function, and Target Genes
1993 • 601 citations
Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.
1995 • 257 citations
Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential
2005 • 239 citations
Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.
1987 • 234 citations
DAB389IL-2 (Denileukin Diftitox, ONTAK): A New Fusion Protein Technology
2000 • 54 citations
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells
1991 • 48 citations
Differential expression of interleukin‐2 receptors (α and β chain) in mature lymphoid neoplasms
1994 • 43 citations
Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
1992 • 41 citations
Elevated Concentration of Soluble Interleukin-2 Receptors in Serum of Smokers and Patients with Lung Cancer: Correlation with Clinical Activity
1990 • 33 citations
Soluble interleukin-2 receptors and other markers in primary lung cancer
1991 • 30 citations
The clinicopathological significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small-cell lung cancer patients
2000 • 24 citations
Interleukin-2 receptors in pulmonary adenocarcinoma tissue
1996 • 21 citations
The clinical significance of serum soluble interleukin-2 receptors in lung cancer
1996 • 16 citations
The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
2001 • 13 citations